Rapid risk/outbreaks assessment aim at supporting the countries and the European Commission in their preparedness and response to a public health threat. They provide a timely summary and risk assessment of a public health threat for EU/EEA countries related to a specific event. They also include potential options for response. As outbreaks or public health events develop, ECDC may issue updated risk assessments.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
On 24 March 2017, the German authorities reported the contamination of a ‘do-it-yourself’ bacterial gene engineering CRISPR kit produced in the US. This publication assesses the risk related to the use of ‘do-it-yourself’ CRISPR-associated gene engineering kit contaminated with pathogenic bacteria.
Following an invitation from Greek authorities, a team of experts from ECDC, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) and the WHO Regional Office for Europe visited Greece in May 2012.
Following a request by the Romanian government, ECDC conducted a second follow-up country visit to Romania covering HIV, sexually transmitted infections (STIs) and hepatitis B and C from 11–13 May 2011.
Following a request by the Estonian government, ECDC performed a follow-up country visit to Estonia covering HIV and sexually transmitted infections (STIs) from 11–13 October 2010.